retatrutide and cjc 1295 cjc-1295 ipamorelin with Retatrutide. BPC-157. CJC-1295. Ipamorelin. TB-500. Tesamorelin CJC-1295 No DAC & Ipamorelin

Mechanism of Action (Research Context) In controlled research environments, retatrutide has been shown to interact with three key metabolic signalling pathways: GLP-1 receptor activity associated with appetite signalling and glucose regulation GIP receptor activity involved in insulin and fat metabolism Glucagon receptor activity linked to energy expenditure and lipid mobilisation This triple-pathway engagement makes retatrutide of particular interest for metabolic and endocrine research models studying obesity, insulin resistance and energy homeostasis

[1] Many patients find the thigh particularly convenient for self-administration, as it offers good visibility and accessibility

Dual Action Mechanism: Targets both GIP and GLP-1 receptors for enhanced metabolic benefits

Fatty liverThe next-strongest signal we're seeing is in the liver

doi: 10.1016/j.ejphar.2016.04.052 165 HolstJJBurcelinRNathansonE